FDA Import Refusal 799-1242690-3/11/1 — Boehringer Ingelheim Pharmaceuticals, Inc.
The FDA refused shipment 799-1242690-3/11/1 from Boehringer Ingelheim Pharmaceuticals, Inc. (United States) on May 3, 2019. The refused product falls under Drugs and Biologics — DABIGATRAN ETEXILATE MESYLATE (ANTI-COAGULANT). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- May 3, 2019
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 61LCY41 DABIGATRAN ETEXILATE MESYLATE (ANTI-COAGULANT)
- Charges
- 75